LEADER misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 4 of 5 of this archive, newest first.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Efficacy was never the question in this appraisal. Duration of treatment was.
A proper account of an operation that existed, and of what closing it cost.
Water is a reactant in hydrolysis, a plasticiser that mobilises the amorphous matrix, and a carrier for everything else. All three matter.
Almost every case involves a change — a new vial, a new syringe size, a new supplier — carried forward with an old number.
Efficacy was never the question in this appraisal. Duration of treatment was.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The document is four pages. Three of them are about dates.
Reported from the sessions, and from the two hours afterwards.
Every third-party report in this market describes a sample somebody chose to send. That choice is outside the laboratory’s control and outside its records.
Every certificate circulating in this market answers a question about molecules. Almost none answers a question about organisms, pyrogens, or the integrity of the seal.
Efficacy was never the question in this appraisal. Duration of treatment was.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The document is four pages. Three of them are about dates.
Reported from the sessions, and from the two hours afterwards.
Two years ago we ran an anonymised version of this comparison and promised a named one. This is it, with every method printed in full.
Stereochemical inversion changes the molecule, changes its biology, and changes its mass by exactly nothing.
What was pre-specified, what was exploratory, and what was calculated afterwards by people who did not run the trial.
The document is four pages. Three of them are about dates.
The route did not close because of a rule about peptides.
Reported from the sessions, and from the two hours afterwards.
The recommendation survives scrutiny. The reasoning offered for it frequently does not.
The evidence base is thin and the document says so, which is to its credit.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Efficacy was never the question in this appraisal. Duration of treatment was.
A proper account of an operation that existed, and of what closing it cost.
We work the arithmetic out in full, because it is arithmetic and it is short.
Endotoxin is the more tractable of the two questions, and a kinetic chromogenic determination is neither slow nor exotic. It is simply not on the menu.
The evidence base is thin and the document says so, which is to its credit.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
The supplier confirmed the determination and supplied the method behind its own figure inside a week.
The observation that closes a facility is rarely the dramatic one.
Every withdrawal trial compared full dose against nothing. The clinically interesting comparison — full dose against a reduced one — has not been randomised.
Almost nothing in the standard management repertoire has been tested in a randomised trial in this specific population. We say what is extrapolated and from where.
The route did not close because of a rule about peptides.
The observation that closes a facility is rarely the dramatic one.
Reported from the sessions, and from the two hours afterwards.
Real-world persistence figures, with their definitions stated, because the definitions are doing most of the work.
Baseline placement under a tailing peak is a judgement call with a direct effect on the area. It is one of the few places where two competent analysts genuinely disagree.
The document is four pages. Three of them are about dates.